Literature DB >> 18228560

African regional external quality assessment for CD4 T-cell enumeration: development, outcomes, and performance of laboratories.

Deborah K Glencross1, Hazel M Aggett, Wendy S Stevens, Frank Mandy.   

Abstract

BACKGROUND: An independent African Regional External Quality Assessment Scheme (AFREQAS) was implemented from Johannesburg. The aim was to establish a network of CD4 laboratories supporting HIV/AIDS anti-retroviral therapy programs and improve the quality of regional CD4 testing with EQA assessment, feedback, remedial action, and technical training. The overall performance from 2002 to 2006 (Trials 1-20) is reported, together with cumulative longitudinal performance of the different CD4 methods used.
METHODS: Stabilized blood samples with "normal" and/or "low" CD4 values were shipped over 20 Trials. Data was analyzed for each trial including trimmed mean, standard deviation, and percentage coefficient of variation (%CV); "Residual" and SDI values were also calculated for each participating laboratory for both absolute CD4 counts (CD4abs) and CD4 percentage of lymphocytes values (CD4%/Ly). Standardized individual laboratory SDI values across 20 trials were analyzed according to CD4 method.
RESULTS: Average participation was 91.5%. Overall AFREQAS between-laboratory reproducibility (trimmed %CV) was 10.5% and 9.1% for absolute CD4 and CD4%/Ly, respectively. For the respective CD4abs and CD4%/Ly values in the trials where "normal" material was shipped trimmed %CV of 10.9 and 7.3% were noted, and in "low" value shipments %CV of 13.8% and 12.4% were noted. Cumulative absolute CD4 SDI analysis revealed the best between-laboratory precision amongst FACSCount and PanLeucogating (PLG-CD4) users (both SD of SDI = <1.2 and %CV of <<8%). Dual Platform or Single Platform algorithm-based systems and certain volumetric methods (laboratories who used Partec CyFlow instruments) had higher numbers of outlying laboratories (>12-25%CV and SD(SDI) > 2.2 noted), indicating that additional technical training and/or manufacturer support was required.
CONCLUSIONS: Participation in an AFREQAS with feedback and remedial action improves the quality of CD4 testing. African laboratory professionals can easily master CD4 counting technologies. However, the introduction of the simplest and most cost-effective methodologies is required to take ownership, and enable the delivery of quality CD4 counts in vast numbers necessary to support expansion of African ART programs. Copyright 2008 Clinical Cytometry Society.

Entities:  

Mesh:

Year:  2008        PMID: 18228560     DOI: 10.1002/cyto.b.20397

Source DB:  PubMed          Journal:  Cytometry B Clin Cytom        ISSN: 1552-4949            Impact factor:   3.058


  23 in total

1.  Dried culture spots for Xpert MTB/RIF external quality assessment: results of a phase 1 pilot study in South Africa.

Authors:  L E Scott; N Gous; B E Cunningham; B D Kana; O Perovic; L Erasmus; G J Coetzee; H Koornhof; W Stevens
Journal:  J Clin Microbiol       Date:  2011-10-05       Impact factor: 5.948

2.  Specimen Referral Network to Rapidly Scale-Up CD4 Testing: The Hub and Spoke Model for Haiti.

Authors:  Frantz Jean Louis; Anna Janick Osborne; Viala Jean Elias; Josiane Buteau; Jacques Boncy; Angela Elong; Amber Dismer; Vikram Sasi; Jean Wysler Domercant; Daniel Lauture; S Arunmozhi Balajee; Barbara J Marston
Journal:  J AIDS Clin Res       Date:  2015-06-26

3.  Impact of proficiency testing program for laboratories conducting early diagnosis of HIV-1 infection in infants in low- to middle-income countries.

Authors:  Albert Garcia; Shambavi Subbarao; Guoqing Zhang; Linda Parsons; John Nkengasong; Chin-Yih Ou; Dennis Ellenberger
Journal:  J Clin Microbiol       Date:  2013-12-18       Impact factor: 5.948

4.  Laboratory Accuracy Improvement in the UK NEQAS Leucocyte Immunophenotyping Immune Monitoring Program: An Eleven-Year Review via Longitudinal Mixed Effects Modeling.

Authors:  John Bainbridge; Wes Rountree; Raul Louzao; John Wong; Liam Whitby; Thomas N Denny; David Barnett
Journal:  Cytometry B Clin Cytom       Date:  2017-05-16       Impact factor: 3.058

5.  External quality assessment of national public health laboratories in Africa, 2002-2009.

Authors:  John Frean; Olga Perovic; Vivian Fensham; Kerrigan McCarthy; Anne von Gottberg; Linda de Gouveia; Bhavani Poonsamy; Leigh Dini; Jenny Rossouw; Karen Keddy; Wondimagegnehu Alemu; Ali Yahaya; Antoine Pierson; Virginie Dolmazon; Sébastien Cognat; Jean Bosco Ndihokubwayo
Journal:  Bull World Health Organ       Date:  2012-01-20       Impact factor: 9.408

6.  Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectiveness.

Authors:  April D Kimmel; Milton C Weinstein; Xavier Anglaret; Sue J Goldie; Elena Losina; Yazdan Yazdanpanah; Eugène Messou; Kara L Cotich; Rochelle P Walensky; Kenneth A Freedberg
Journal:  J Acquir Immune Defic Syndr       Date:  2010-07       Impact factor: 3.731

7.  Performance evaluation of the MBio Diagnostics point-of-care CD4 counter.

Authors:  Cathy Logan; Monique Givens; Jeffrey T Ives; Marie Delaney; Michael J Lochhead; Robert T Schooley; Constance A Benson
Journal:  J Immunol Methods       Date:  2012-10-11       Impact factor: 2.303

8.  How to estimate the cost of point-of-care CD4 testing in program settings: an example using the Alere Pima Analyzer in South Africa.

Authors:  Bruce Larson; Kathryn Schnippel; Buyiswa Ndibongo; Lawrence Long; Matthew P Fox; Sydney Rosen
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

Review 9.  Low-cost assays for monitoring HIV infected individuals in resource-limited settings.

Authors:  Pachamuthu Balakrishnan; Hussain Syed Iqbal; Saravanan Shanmugham; Janardhanan Mohanakrishnan; Sunil S Solomon; Kenneth H Mayer; Suniti Solomon
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

10.  Performance evaluation of the Pima™ point-of-care CD4 analyser using capillary blood sampling in field tests in South Africa.

Authors:  Deborah K Glencross; Lindi M Coetzee; Mamsallah Faal; Martin Masango; Wendy S Stevens; Wd Francois Venter; Regina Osih
Journal:  J Int AIDS Soc       Date:  2012-01-30       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.